In other countries
The same active substances on other registers, the same brand first.
- InrebicCanada · 100 MG · Capsule · Bristol-Myers Squibb CanadaSame brand
- InrebicEuropean Union · Bristol Myers Squibb Pharma EEIGSame brand
- InrebicCroatiaSame brand
- Inrebic 100 mg, harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame brand
- Inrebic Capsules 100 MGSingapore · 100 mg · capsule · Bristol-Myers Squibb (Singapore) Pte. LTD.Same brand
- InrebicUnited States · 100MG BASE · capsule · Bristol-MyersSame brand
Packs
| Pack | Code | Status |
|---|---|---|
| 100 MG - CAPSULA RIGIDA - USO ORALE - FLACONE (HDPE) - 120 CAPSULE | 049373018 | Autorizzata |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Fedratinib
- Dosage form
- Capsula rigida
- Register
- Italy (AIFA)
- Status
- Authorised
- Status in the register
- Autorizzata
- Registration
- AIC 049373
- Marketing authorisation holder
- Bristol-Myers Squibb Pharma Eeig
- ATC code
- L01EJ02
- Procedure
- Procedura Centralizzata
- Supply
- Medicinali soggetti a prescrizione medica limitativa, da rinnovare volta per volta, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti